CD79A and COVID-19: We also determined the specificities of the four immunoassays (EUR S-IgA, EUR S-IgG, EUR N-IgG, Roche-Ab) using a pre-COVID-19 cohort of healthy individuals and in a PCR-negative clinical cohort of patients presenting with COVID-19-like symptoms (Table 2).